Tokyo, Sept. 2 -- National Cancer Center Research Institute - Tokyo has issued a Notice of Procurement (Goods & Services) on Sep 01, 2025. Here are other related details:
Classification:
0004 Medical & Pharmaceutical Products
Summary:
⑴ Official in charge of disbursement of the procuring entity : Hiroyuki Mano, Director, National Cancer Center
⑵ Classification of the services to be procured : 4
⑶ Nature and quantity of the products to be purchased : Drug radioactivity, etc. unit price contract (Central/East)
⑷ Fulfillment period : From December 1, 2025 through November 30, 2026
⑸ Delivery place : National Cancer Center (Tsukiji, Kashiwa)
⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
① not come under Article 6 of the Handling detailed rule of contract clerical work of National Cancer Center. Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;
② not come under Article 7 of the Handling detailed rule of contract clerical work of National Cancer Center ;
③ have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health Labour and Welfare (Single qualification for every ministry and agency) in Kanto-Koshinetsu Region ;
④ prove to have obtained the firstclasslicense for selling drugs in accordance with the Pharmaceutical Affairs Law ;
⑤ join social insurance (welfare annuity insurance, health insurance, seamen's insurance, national pension, worker's compensation insurance, unemployment insurance) and pay the social insurance premiums and have no Delinquency in the past 2 years
⑺ Time-limit for tender : 5 : 00 PM October 31, 2025
⑻ Contact point for the notice : Procurement Contract Devision, National Cancer Center, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. TEL 03-3547-5201 ext. 2651
Disclaimer: Curated by HT Syndication.
